SCHEMBL4359776

SCHEMBL4359776

CCCCCC(O)C1CC1

nearest known ligand 0.60

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 3/20 0.40
SPHK1 Q9NYA1 1/20 0.40
FFAR1 O14842 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9173056 1.00 GPR84 (0.40) GPR84SPHK1FFAR1
SCHEMBL9173346 0.98 GPR84 (0.43) GPR84SPHK1FFAR1
SCHEMBL17099449 0.98 GPR84 (0.43) GPR84SPHK1FFAR1
SCHEMBL31562884 0.98 GPR84 (0.43) GPR84SPHK1FFAR1
SCHEMBL3490657 0.98 GPR84 (0.43) GPR84SPHK1FFAR1
SCHEMBL1663576 0.91 TP53 (0.45)
SCHEMBL4535941 0.89 TP53 (0.48)
SCHEMBL9558017 0.89 GPR84 (0.41) GPR84SPHK1FFAR1
SCHEMBL3427003 0.89 TP53 (0.43)
SCHEMBL11607011 0.87 TP53 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090312558-A1 PROCESS FOR THE PREPARATION OF ARYLCYCLOPROPOANE CARBOXYLIC CARBONITRILES, AND COMPOUNDS DERIVED THEREFROM RELIANCE LIFE SCIENCES PVT. LTD. (IN) 2009-12-17 US claimed
WO-2009150660-A1 A PROCESS FOR THE PREPARATION OF ARYLCYCLOPROPANE CARBOXYLIC CARBONITRILES, AND COMPOUNDS DERIVED THEREFROM RELIANCE LIFE SCIENCES PVT. LTD. (IN) 2009-12-17 WO claimed
JP-3141233-A None JP disclosed
JP-6271484-A None JP disclosed
WO-2023143399-A1 STEROID COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 珂阑(上海)医药科技有限公司 2023-08-03 WO disclosed
US-20090312558-A1 PROCESS FOR THE PREPARATION OF ARYLCYCLOPROPOANE CARBOXYLIC CARBONITRILES, AND COMPOUNDS DERIVED THEREFROM RELIANCE LIFE SCIENCES PVT. LTD. (IN) 2009-12-17 US disclosed
WO-2009150660-A1 A PROCESS FOR THE PREPARATION OF ARYLCYCLOPROPANE CARBOXYLIC CARBONITRILES, AND COMPOUNDS DERIVED THEREFROM RELIANCE LIFE SCIENCES PVT. LTD. (IN) 2009-12-17 WO disclosed
JP-H06271484-A PRODUCTION OF DIHYDRONAPHTHALENES SUMITOMO CHEM CO LTD 1994-09-27 JP disclosed
JP-H03141233-A HALONAPHTHALENE DERIVATIVE, PREPARATION AND INTERMEDIATE THEREOF SUMITOMO CHEM CO LTD 1991-06-17 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312558-A1 PROCESS FOR THE PREPARATION OF ARYLCYCLOPROPOANE CARBOXYLIC CARBONITRILES, AND COMPOUNDS DERIVED THEREFROM NOTUM, SULT2A1, SULT1A1 GPR84 1977/4885SPHK1 1473/4885FFAR1 349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.